Researchers have solved the longstanding mystery of the mechanisms behind the effects of anesthetics.

Molecules released into the blood following mild traumatic brain injury may be indicators of neuronal damage associated with complications, according to new research.

A team from Duke University has developed a synthetic molecule that selectively dampens the physiological rewards of cocaine in mice. This molecule could represent a new class of drugs that may be more specific that currently available medications, with fewer adverse effects.

A study has discovered two potential candidates to treat Alzheimer’s disease. The two marine molecules, meridianine and lignarenone B, can alter the activity of GSK3B activity, a protein linked to several neurodegenerative diseases.

A potential blood-based biomarker for Alzheimer's and other neurodegenerative diseases seems even more promising thanks to new research from a Massachusetts General Hospital-led study.

An international research team has for the first time obtained the structure of the light-sensitive sodium-pumping KR2 protein in its active state.

On December 31, 2019, the first cases of a novel coronavirus were identified in Wuhan City, Hubei Province, China. Here, we curate a collection of news and content related to the outbreak.

Ever wonder what happens in your brain to make the switch between exhaustion and over-caffeination after a few cups of coffee? New research has teased out information about "brain states" and how changes in our neurons' activity and synchronization drive these switches in our brain and behavior.

Adventure sports materials provider NOVA has spent decades making safety equipment. But the recent COVID-19 pandemic has seen the Austrian company repurpose their products to fight viruses rather than prevent skydiving accidents.

The #PostItNotePhD challenge asked scientists to summarize their PhD on a single post-it note. Here are a selection of Technology Networks' favorites.

It is an extraordinary time, but it is not an excuse for lowering scientific standards, argue Professor Jonathan Kimmelman, McGill University, and Professor Alex John London, Carnegie Mellon University, in a Policy Forum published in the journal Science . Technology Networks spoke with Kimmelman in a recent interview to gain his insights on research exceptionalism.

In a recent interview with Technology Networks, Marcus Walker and Matthew Donora from Open Cell, a startup lab facility in London that has created testing labs inside shipping containers, explained in greater detail exactly why testing is so important to combating a pandemic.